Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 17 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
ATPHARMA from Schoten, company number BE0465773610, closed financial year 2025 with a result of € 55,503 after tax. For that financial year ATPHARMA recorded a gross margin of € 148,228 and equity of € 198,351. Compared with financial year 2024, the result moved from € 45,893 to € 55,503. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.
€ 198,351
▲ 39% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 55,503
▲ 21% vs 2024
Profit after tax over the fiscal year.
€ 47,609
▲ 268% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 136,851.
Debts at end 2025
€ 366,198
▼ 19% vs 2024
€ 59,475 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 186
▼ 92% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 14,777
▲ € 14,154 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 194,975 | € 135,565 | € 121,428 | € 148,228 | ▲ 22% |
| Profit after taxes | € 57,403 | € 56,278 | € 45,893 | € 55,503 | ▲ 21% |
| Equity | € 124,677 | € 138,955 | € 142,848 | € 198,351 | ▲ 39% |
| Total debts | € 757,035 | € 709,286 | € 656,579 | € 594,272 | ▼ 9% |
| Cash | € 26,485 | € 19,239 | € 12,935 | € 47,609 | ▲ 268% |
| Land & buildings | € 831,640 | - | € 765,485 | € 732,453 | ▼ 4% |
| Retained profit | € 63,177 | € 77,455 | € 81,348 | € 136,851 | ▲ 68% |
| Dividend | € 42,000 | € 42,000 | € 42,000 | € 0 | ▼ 100% |
| Bank debt | € 604,941 | € 529,537 | € 452,571 | € 366,198 | ▼ 19% |
| Balance sheet total | € 881,711 | € 848,241 | € 799,427 | € 792,623 | ▼ 1% |
By gross margin, ATPHARMA ranks 4th of 28 companies with main activity “Ontwerpen van computerprogramma’s” in Schoten that publish figures (fiscal year 2025).
Key figures of ATPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
Ask about ATPHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to ATPHARMA?
What happened at ATPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 55,503 (▲ 21% vs 2024). Source: NBB ↗
- New establishment in Schoten. KBO
- Start of the company according to the CBE. KBO
In short
From € 57,403 profit in 2022 to € 55,503 profit in 2025.
Paid € 35,189 in corporate taxes since 2022.
Best year ever: 2022, with € 57,403 profit.
Paid out € 126,000 in dividends to the owners in total.
Establishments
Establishment units
Physical locations of this company
Ganzendreef 1
2900 Schoten
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Schoten
Same main activity (Ontwerpen van computerprogramma’s), 33 active companies in Schoten, largest first.
€ 1.4 million gross margin · 2025
€ 388,587 gross margin · 2025
€ 204,367 gross margin · 2025
€ 139,704 gross margin · 2025
€ 126,702 gross margin · 2025
€ 126,398 gross margin · 2025
Details
- Company number
- 0465.773.610
- VAT number
- BE 0465.773.610
- Registered office
- Ganzendreef 1, 2900 Schoten
- Names & denominations
- ATPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 1 April 1999
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Ontwerpen van computerprogramma’s
Overige advisering in verband met programmatuur en levering van programmatuur
Ontwerpen en programmeren van computerprogramma's
Verhuur en lease van kantoormachines, inclusief computers
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Verhuur van kantoormachines en computers